NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000046549

Registered date:05/01/2022

Prolonged Emergence from General Anesthesia with Remimazolam; Retrospective Observational Study

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedpatients undergoing elective surgery under general anesthesia with remimazolam
Date of first enrollment2020/11/04
Target sample size100
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary Outcomepredictive plasma concentrations of remimazolam at the end of remimazolam infusion and upon at the extubation, the total dose of remimazolam
Secondary Outcomeage, sex, height, body weight, body mass index (BMI), plasma albumin concentration, ASA class, duration of surgery, and total duration of general anesthesia

Key inclusion & exclusion criteria

Age minimum15years-old
Age maximum100years-old
GenderMale and Female
Include criteria
Exclude criterianone

Related Information

Contact

public contact
Name Michiyoshi Sanuki
Address 3-1 Aoyama, Kure, Hiroshima, Japan Japan 737-0023
Telephone 0823-22-3111
E-mail msanuki@ff.iij4u.or.jp
Affiliation National Hospital Organization Kure Medical Center and Chugoku Cancer Center Department of Anesthesiology
scientific contact
Name Yoko Shimamoto
Address 3-1 Aoyama, Kure, Hiroshima, Japan Japan
Telephone 0823-22-3111
E-mail j036eb@yahoo.co.jp
Affiliation National Hospital Organization Kure Medical Center and Chugoku Cancer Center Department of Anesthesiology